Literature DB >> 12649342

Molecular diagnosis of oligodendroglioma in paraffin sections.

Kimmo J Hatanpaa1, Peter C Burger, James R Eshleman, Kathleen M Murphy, Karin D Berg.   

Abstract

Distinction of oligodendrogliomas from other gliomas is clinically important, but the histologic diagnosis of oligodendroglioma has been a difficult and notoriously subjective task. Testing for loss of heterozygosity (LOH) on chromosomal arms 1p and 19q, the genetic signature of oligodendroglioma, has emerged as a useful, objective adjunct to the traditional histologic evaluation. However, LOH testing of glioma specimens has not yet been widely implemented, presumably because of a lack of a practical LOH assay. We describe a 1p and 19q LOH assay suitable for routine diagnostics. In contrast to traditional microsatellite-based LOH analysis, we show that detection of LOH is usually possible even without normal tissue or blood from the same patient. A small area of tumor on a single paraffin section is sufficient for the assay. The assay protocol consists of a one-step DNA extraction, multiplex PCR for microsatellites on 1p and 19q, and capillary electrophoresis of the PCR products. LOH is detected by analysis of the allelic patterns and by integration of data from multiple highly polymorphic microsatellites. In a validation study on 19 gliomas, the results were concordant with results obtained by established methods and correlated well with histologic diagnoses. Because only a paraffin section is required, the pathologist can perform both the traditional histopathologic evaluation and this supporting molecular assay from the material at hand.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12649342     DOI: 10.1097/01.lab.0000059948.67795.ef

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  27 in total

Review 1.  Molecular diagnostics: techniques and recommendations for 1p/19q assessment.

Authors:  Adelheid Woehrer; Johannes A Hainfellner
Journal:  CNS Oncol       Date:  2015-11-06

2.  Genomic changes in gliomas detected using single nucleotide polymorphism array in formalin-fixed, paraffin-embedded tissue: superior results compared with microsatellite analysis.

Authors:  Shuko Harada; Lindsay B Henderson; James R Eshleman; Christopher D Gocke; Peter Burger; Constance A Griffin; Denise A S Batista
Journal:  J Mol Diagn       Date:  2011-07-02       Impact factor: 5.568

3.  Multiplex ligation-dependent probe amplification: a diagnostic tool for simultaneous identification of different genetic markers in glial tumors.

Authors:  Judith Jeuken; Sandra Cornelissen; Sandra Boots-Sprenger; Sabine Gijsen; Pieter Wesseling
Journal:  J Mol Diagn       Date:  2006-09       Impact factor: 5.568

4.  Extraventricular anaplastic ependymoma with metastasis to scalp and neck.

Authors:  Matthew J Davis; Fauzia Hasan; Ilan Weinreb; M Christopher Wallace; Tim-Rasmus Kiehl
Journal:  J Neurooncol       Date:  2011-01-11       Impact factor: 4.130

5.  Clinicopathologic features of pediatric oligodendrogliomas: a series of 50 patients.

Authors:  Fausto J Rodriguez; Tarik Tihan; Doris Lin; William McDonald; Janice Nigro; Burt Feuerstein; Sadhana Jackson; Kenneth Cohen; Peter C Burger
Journal:  Am J Surg Pathol       Date:  2014-08       Impact factor: 6.394

6.  Anaplastic glioma after high-dose proton-photon radiation treatment for low-grade skull base chondrosarcoma.

Authors:  Sepehr Ehsani; Mojgan Hodaie; Norbert J Liebsch; Fred Gentili; Tim-Rasmus Kiehl
Journal:  J Neurooncol       Date:  2008-06       Impact factor: 4.130

Review 7.  Molecular diagnostics of gliomas: state of the art.

Authors:  Markus J Riemenschneider; Judith W M Jeuken; Pieter Wesseling; Guido Reifenberger
Journal:  Acta Neuropathol       Date:  2010-08-17       Impact factor: 17.088

8.  Molecular diagnosis of metastasizing oligodendroglioma: a case report.

Authors:  Min Wang; Kathleen M Murphy; Piotr Kulesza; Kimmo J Hatanpaa; Alessandro Olivi; Anthony Tufaro; Yener Erozan; William H Westra; Peter C Burger; Karin D Berg
Journal:  J Mol Diagn       Date:  2004-02       Impact factor: 5.568

9.  Differentiation between oligodendroglioma genotypes using dynamic susceptibility contrast perfusion-weighted imaging and proton MR spectroscopy.

Authors:  S Chawla; J Krejza; A Vossough; Y Zhang; G S Kapoor; S Wang; D M O'Rourke; E R Melhem; H Poptani
Journal:  AJNR Am J Neuroradiol       Date:  2013-01-31       Impact factor: 3.825

10.  LOH in the HLA class I region at 6p21 is associated with shorter survival in newly diagnosed adult glioblastoma.

Authors:  Jacky T Yeung; Ronald L Hamilton; Koji Ohnishi; Maki Ikeura; Douglas M Potter; Marina N Nikiforova; Soldano Ferrone; Regina I Jakacki; Ian F Pollack; Hideho Okada
Journal:  Clin Cancer Res       Date:  2013-02-11       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.